Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1949 1
1950 2
1951 1
1952 1
1953 3
1954 1
1955 1
1957 1
1958 3
1959 3
1960 4
1961 2
1962 2
1963 1
1964 4
1965 2
1966 6
1967 4
1968 3
1969 3
1970 4
1971 8
1972 12
1973 7
1974 10
1975 12
1976 12
1977 17
1978 11
1979 14
1980 9
1981 11
1982 15
1983 10
1984 19
1985 25
1986 18
1987 24
1988 26
1989 16
1990 14
1991 27
1992 34
1993 28
1994 38
1995 37
1996 48
1997 31
1998 48
1999 38
2000 44
2001 46
2002 39
2003 54
2004 58
2005 62
2006 65
2007 71
2008 92
2009 100
2010 79
2011 102
2012 97
2013 105
2014 129
2015 123
2016 128
2017 142
2018 148
2019 144
2020 194
2021 205
2022 167
2023 134
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

2,893 results

Results by year

Filters applied: . Clear all
Page 1
A highly efficient transgene knock-in technology in clinically relevant cell types.
Allen AG, Khan SQ, Margulies CM, Viswanathan R, Lele S, Blaha L, Scott SN, Izzo KM, Gerew A, Pattali R, Cochran NR, Holland CS, Zhao AH, Sherman SE, Jaskolka MC, Wu M, Wilson AC, Sun X, Ciulla DM, Zhang D, Nelson JD, Zhang P, Mazzucato P, Huang Y, Giannoukos G, Marco E, Nehil M, Follit JA, Chang KH, Shearman MS, Wilson CJ, Zuris JA. Allen AG, et al. Among authors: sherman se. Nat Biotechnol. 2024 Mar;42(3):458-469. doi: 10.1038/s41587-023-01779-8. Epub 2023 May 1. Nat Biotechnol. 2024. PMID: 37127662
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Brose MS, Robinson BG, Sherman SI, Jarzab B, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Sen S, Oliver JW, Banerjee K, Keam B, Capdevila J. Brose MS, et al. Among authors: sherman si. Cancer. 2022 Dec 15;128(24):4203-4212. doi: 10.1002/cncr.34493. Epub 2022 Oct 19. Cancer. 2022. PMID: 36259380 Free PMC article. Clinical Trial.
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Li Z, Chang TC, Junco JJ, Devidas M, Li Y, Yang W, Huang X, Hedges DJ, Cheng Z, Shago M, Carroll AJ, Heerema NA, Gastier-Foster J, Wood BL, Borowitz MJ, Sanclemente L, Raetz EA, Hunger SP, Feingold E, Rosser TC, Sherman SL, Loh ML, Mullighan CG, Yu J, Wu G, Lupo PJ, Rabin KR, Yang JJ. Li Z, et al. Among authors: sherman sl. Blood. 2023 Jul 13;142(2):172-184. doi: 10.1182/blood.2023019765. Blood. 2023. PMID: 37001051
Dyspneic and dizzy.
Thapi S, Tsega S, Zhao C, Olson APJ, Sherman SV. Thapi S, et al. Among authors: sherman sv. J Hosp Med. 2022 Aug;17(8):657-660. doi: 10.1002/jhm.12815. Epub 2022 Mar 30. J Hosp Med. 2022. PMID: 35535933 No abstract available.
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Brose MS, Robinson B, Sherman SI, Krajewska J, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Hernando J, Faoro L, Banerjee K, Oliver JW, Keam B, Capdevila J. Brose MS, et al. Among authors: sherman si. Lancet Oncol. 2021 Aug;22(8):1126-1138. doi: 10.1016/S1470-2045(21)00332-6. Epub 2021 Jul 5. Lancet Oncol. 2021. PMID: 34237250 Clinical Trial.
Outside looking in.
Rezigh AB, Rezigh A, Kanjee Z, Sargsyan Z, Sherman S, Kumfer AM. Rezigh AB, et al. Among authors: sherman s. J Hosp Med. 2023 Jul;18(7):633-637. doi: 10.1002/jhm.13011. Epub 2022 Nov 30. J Hosp Med. 2023. PMID: 36451344 No abstract available.
Reply by Authors.
Matulewicz RS, Basak R, Zambrano I, Dearing BA, Schatz D, El Shahawy O, Sherman S, Bjurlin MA. Matulewicz RS, et al. Among authors: sherman s. J Urol. 2021 May;205(5):1451. doi: 10.1097/JU.0000000000001483.02. Epub 2021 Mar 11. J Urol. 2021. PMID: 33705219 No abstract available.
Technological review: developments in innovative duodenoscopes.
Gromski MA, Sherman S. Gromski MA, et al. Among authors: sherman s. Gastrointest Endosc. 2022 Jan;95(1):42-50. doi: 10.1016/j.gie.2021.08.019. Epub 2021 Sep 4. Gastrointest Endosc. 2022. PMID: 34487777 Review. No abstract available.
2,893 results